Opus Genetics (IRD) Enterprise Value (2010 - 2026)
Opus Genetics (IRD) reported Enterprise Value of -$60.0 million for Q1 2026, down 43.44% year-over-year from -$106.0 million in Q1 2025, and down 32.97% on a QoQ basis from -$45.1 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Enterprise Value data on file, last reported at -$60.0 million in Q1 2026.
- Quarterly Enterprise Value fell 43.44% year-over-year to -$60.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60.0 million (down 43.44% YoY) and the FY2025 annual result came in at -$45.1 million, down 48.7% from the prior year.
- Enterprise Value retreated to -$60.0 million in Q1 2026 per IRD's latest filing, from -$45.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$14.0 million in Q3 2022 and bottomed at -$60.0 million in Q1 2026.
- The 5-year median for Enterprise Value is -$40.0 million (2023), against an average of -$37.1 million.
- The widest annual swing landed in 2023, when Enterprise Value slumped 203.89%; it then soared 39.97% in 2024.
- Tracing IRD's Enterprise Value over 5 years: stood at -$42.7 million in 2022, then decreased by 18.35% to -$50.5 million in 2023, then soared by 39.97% to -$30.3 million in 2024, then slumped by 48.7% to -$45.1 million in 2025, then slumped by 32.97% to -$60.0 million in 2026.
- Per Business Quant, the three latest IRD Enterprise Value figures stand at -$60.0 million (Q1 2026), -$45.1 million (Q4 2025), and -$30.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -59.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.96 Mn |
| Dec 31, 2025 | -45.09 Mn |
| Sep 30, 2025 | -30.80 Mn |
| Jun 30, 2025 | -32.43 Mn |
| Mar 31, 2025 | -41.80 Mn |
| Dec 31, 2024 | -30.32 Mn |
| Sep 30, 2024 | -36.60 Mn |
| Jun 30, 2024 | -41.41 Mn |
| Mar 31, 2024 | -47.17 Mn |
| Dec 31, 2023 | -50.52 Mn |
| Sep 30, 2023 | -42.41 Mn |
| Jun 30, 2023 | -40.02 Mn |
| Mar 31, 2023 | -39.01 Mn |
| Dec 31, 2022 | -42.68 Mn |
| Sep 30, 2022 | -13.96 Mn |
| Jun 30, 2022 | -17.15 Mn |
| Mar 31, 2022 | -19.38 Mn |
| Dec 31, 2021 | -24.75 Mn |
| Sep 30, 2021 | -22.63 Mn |
| Jun 30, 2021 | -24.23 Mn |
| Mar 31, 2021 | -10.60 Mn |
| Dec 31, 2020 | -16.40 Mn |
| Sep 30, 2020 | -8.08 Mn |
| Jun 30, 2020 | -9.21 Mn |
| Mar 31, 2020 | -11.00 Mn |
| Dec 31, 2019 | -4.53 Mn |
| Sep 30, 2019 | -13.91 Mn |
| Jun 30, 2019 | -16.26 Mn |
| Mar 31, 2019 | -18.02 Mn |
| Dec 31, 2018 | -14.73 Mn |
| Sep 30, 2018 | -12.57 Mn |
| Jun 30, 2018 | -16.74 Mn |
| Mar 31, 2018 | -21.18 Mn |
| Dec 31, 2017 | -26.83 Mn |
| Sep 30, 2017 | -23.20 Mn |
| Jun 30, 2017 | -26.78 Mn |
| Mar 31, 2017 | -18.50 Mn |
| Dec 31, 2016 | -20.32 Mn |
| Sep 30, 2016 | -21.81 Mn |
| Jun 30, 2016 | -19.40 Mn |
| Mar 31, 2016 | -24.47 Mn |
| Dec 31, 2015 | -23.44 Mn |
| Sep 30, 2015 | -21.46 Mn |
| Jun 30, 2015 | -25.98 Mn |
| Mar 31, 2015 | -29.39 Mn |
| Dec 31, 2014 | -32.70 Mn |
| Sep 30, 2014 | -35.59 Mn |
| Jun 30, 2014 | -38.20 Mn |
| Mar 31, 2014 | -40.17 Mn |
| Dec 31, 2013 | -18.79 Mn |
| Sep 30, 2013 | -14.97 Mn |
| Jun 30, 2013 | -10.08 Mn |
| Mar 31, 2013 | -12.17 Mn |
| Dec 31, 2012 | -13.59 Mn |
| Sep 30, 2012 | -7.48 Mn |
| Jun 30, 2012 | -8.58 Mn |
| Mar 31, 2012 | -10.05 Mn |
| Dec 31, 2011 | -11.81 Mn |
| Sep 30, 2011 | -15.17 Mn |
| Jun 30, 2011 | -18.08 Mn |
| Mar 31, 2011 | -20.51 Mn |
| Dec 31, 2010 | -14.79 Mn |
| Sep 30, 2010 | -15.83 Mn |
| Jun 30, 2010 | -17.81 Mn |